Triazole Derivatives As Kinase Inhibitors

Patent No. EP2057158 (titled "Triazole Derivatives As Kinase Inhibitors") was filed by Cellzome on Aug 30, 2007. The application was issued on Sep 30, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GODDARDMay 12, 2016GODDARD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2057158

CELLZOME
Application Number
EP07803060A
Filing Date
Aug 30, 2007
Status
Revoked
May 18, 2018
Publication Date
Sep 30, 2015